It was thus of interest to characterize the riboflavin+NOTCH1+ populations isolated from untreated lung cancer cells (hereafter referred to as the cisplatin-naïve population), and the surviving cells after being exposed to 4 cycles of cisplatin treatment (hereafter referred to as the cisplatin-exposed population). The gene discussed is NOTCH1; the disease is lung carcinoma.